Why Keurig Dr Pepper Stock Tanked by More Than 11% Today
The Motley Fool· 2025-08-25 21:28
Investors clearly found the taste of the beverage conglomerate's latest deal sour.Keurig Dr Pepper (KDP -11.34%), a beverage conglomerate built on acquisitions, announced its latest purchase on Monday -- and investors weren't too happy to hear the news. Assertively trading out of the company's stock, they left it with an over 11% loss on the day. By comparison, the S&P 500 index did well with its 0.4% decrease. Brewing up a new coffee giantThat morning, KDP announced it had entered into a definitive agreeme ...
Levi & Korsinsky Notifies Tesla, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – TSLA
GlobeNewswire News Room· 2025-08-25 21:28
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Tesla, Inc. ("Tesla, Inc." or the "Company") (NASDAQ: TSLA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Tesla, Inc. investors who were adversely affected by alleged securities fraud between April 19, 2023 and June 22, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/tesla-inc-lawsuit-submissio ...
Shareholders of Snap Inc. Should Contact Levi & Korsinsky Before October 20, 2025 to Discuss Your Rights – SNAP
GlobeNewswire News Room· 2025-08-25 21:26
Core Viewpoint - A class action securities lawsuit has been filed against Snap Inc. due to alleged securities fraud that negatively impacted investors between April 29, 2025, and August 5, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Snap provided overly positive statements while concealing material adverse facts about its advertising revenue growth rate, which dropped from 9% in Q1 to only 1% in April 2025 [2] - Following the announcement of its Q2 2025 financial results on August 5, 2025, Snap disclosed a slowdown in advertising revenue growth, attributing it to issues with its ad platform and other factors [2] - Snap's stock price fell from $9.39 per share on August 5, 2025, to $7.78 per share on August 6, 2025, marking a decline of approximately 17.15% in one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until October 20, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]
Starcore International Mines Ltd. Announces Private Placement
Newsfile· 2025-08-25 21:24
Vancouver, British Columbia--(Newsfile Corp. - August 25, 2025) - Starcore International Mines Ltd. (TSX: SAM) (the "Company") announces it has approved a non-brokered private placement for gross proceeds of up to $5,000.000. The private placement will consist of up to 20,000,000 units at a price of $0.25 per unit. Each unit is comprised of one common share of Starcore and one-half of one transferable common share purchase warrant, each whole warrant exercisable for a period of two years from the date of i ...
Body and Mind Inc. Announces Agreement to Divest from New Jersey
Newsfile· 2025-08-25 21:24
Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - August 25, 2025) - Body and Mind Inc. (CSE: BAMM) (OTC: BMMJ) (the "Company" or "BaM") is pleased to announce the Company's wholly owned subsidiary, DEP Nevada, Inc. ("DEP") has entered into a Purchase Agreement with Ascend New Jersey, LLC (the "Purchaser"), whereby DEP, which owns 100% of BaM Body and Mind Dispensary NJ, Inc. ("BAM NJ") agrees to sell all of the equity interests (the "Interests") in BAM NJ to the Purchaser.The total cons ...
Hims & Hers Health, Inc. Class Action: Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 – HIMS
GlobeNewswire News Room· 2025-08-25 21:18
Core Viewpoint - A class action securities lawsuit has been filed against Hims & Hers Health, Inc. alleging securities fraud that negatively impacted investors between April 29, 2025, and June 23, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Hims was involved in the deceptive promotion and sale of illegitimate versions of Wegovy®, which posed risks to patient safety [2]. - It is alleged that this situation created a significant risk of termination of the Company's collaboration with Novo Nordisk [2]. - The defendants' positive statements regarding the Company's business and prospects were claimed to be materially misleading and lacked a reasonable basis [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until August 25, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].
Canadian National Faces Tariffs, Trade Strains, And Slow Freight - But I Am Not Selling A Share
Seeking Alpha· 2025-08-25 21:16
Group 1 - The article emphasizes the importance of evaluating Class 1 railroads based on earning power, operating efficiency, and long-term profitability rather than just valuation metrics [1] - It highlights that sustained profitability, characterized by strong margins, stable and expanding free cash flow, and high returns on invested capital, is a more reliable driver of returns [1] - The author manages a portfolio on eToro, focusing on undervalued growth stocks and high-quality dividend growers, indicating a strategic investment approach [1] Group 2 - The author has a diverse academic background, which enhances both quantitative analysis and the interpretation of market narratives [1] - The investment philosophy is centered around ensuring financial freedom through wise asset management, rather than seeking to avoid work altogether [1]
Why Iovance Biotherapeutics Stock Got Mashed on Monday
The Motley Fool· 2025-08-25 21:15
The company announced a flotation of its common shares that is potentially quite dilutive.Monday won't go down as a particularly memorable trading session on the stock market. It also won't be marked as a great day for shareholders of biotech Iovance Biotherapeutics (IOVA -5.76%). The company spooked investors with the disclosure that it's embarking on a new round of potentially dilutive capital raising.That sent the company's share price down by nearly 6% today, quite some distance down the ladder from the ...
GoldMining Files Early Warning Report
Prnewswire· 2025-08-25 21:15
VANCOUVER, BC, Aug. 25, 2025 /PRNewswire/ - GoldMining Inc. (the "Company") has disposed of 1,500,000 common shares ("Shares") of NevGold Corp. ("NevGold") pursuant to block trades over the facilities of the TSX Venture Exchange.Prior to the disposition, the Company beneficially owned and exercised control and direction over 24,073,350 NevGold Shares, representing approximately 21.1% of the outstanding NevGold Shares. After the disposition, the Company beneficially owned and exercised control and direction ...
Waystar Named Healthcare Company of the Year and Top-Ranked AI Software Platform in the 2025 Stevie® Awards
Prnewswire· 2025-08-25 21:15
Recognitions underscore breakthrough innovations, meaningful client outcomes at scale, and leadership driving healthcare's AI transformationLEHI, Utah and LOUISVILLE, Ky., Aug. 25, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it earned multiple Gold Stevie® Awards in the 2025 International Business Awards®, including Healthcare Company of the Year and Top-Ranked AI Software Platform for Waystar AltitudeAI™. Waystar's Auth Accelerate solution ...